Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma.
Kim DW, Chung K, Chung WK, Bae SH, Shin DO, Hong S, Park SH, Park SY, Hong CS, Lim YK, Shin D, Lee SB, Lee HH, Sung J, Yoon M.
Kim DW, et al. Among authors: chung k, chung wk.
Radiat Oncol. 2014 May 8;9:109. doi: 10.1186/1748-717X-9-109.
Radiat Oncol. 2014.
PMID: 24886163
Free PMC article.
Clinical Trial.